Clinical development of fibrinolytic medicinal products in the treatment of patients with ST -segment elevation acute myocardial infarction (STEMI)

  • Email
  • Help
Current effective version

This document has been superseded by Guideline on clinical investigation of new medicinal products for the treatment of acute coronary syndrome (EMA/CHMP/760125/2016)

Reference numberCPMP/EWP/6235/04
Published26/06/2003
Effective from01/12/2003
KeywordsST segment elevation, acute coronary syndrome, myocardial infarction, angina, revascularisation, anticoagulants, antithrombotics, stent thrombosis
DescriptionThis document provides guidance on the clinical development of new fibrinolytics in the treatment of patients with ST segment elevation acute myocardial infarction.


Document history

Revision 1 

Draft guideline
 

Concept paper

Published: 15/10/2014
 

Published: 15/10/2014

First versionAdopted guidelineIn operation: 01/12/2003 - 01/03/2018


Related content


How helpful is this page?

Average rating:

 Based on 0 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
0 ratings
    

Tell us more